Serrated adenoma of the colorectum and the DNA-methylator phenotype
- 1 August 2005
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 2 (8), 398-405
- https://doi.org/10.1038/ncponc0248
Abstract
Serrated adenomas (SA) of the colorectum show features intermediate between hyperplastic polyps (HP) and adenomas. HP and SA are related lesions and there is now strong evidence for a 'serrated-polyp pathway' to colorectal cancer (CRC) that is largely independent of the classic adenoma-to-carcinoma sequence. A recently recognized lesion in this pathway is a HP variant characterized by relatively large size, atypical histology and proximal location in the colorectum. This HP variant has been given a variety of names in the literature including 'sessile SA' and 'type I SA'. Because this lesion lacks the traditional cytology of colorectal adenoma and in order to avoid confusion with SA, it is referred to in this review as sessile serrated polyp. SA are characterized by a heterogeneous group of changes at the molecular level, but a high proportion have BRAF mutations and DNA methylation. They may develop in HP or sessile serrated polyps, or may arise de novo. In the serrated-polyp pathway, the advent of genetic instability is likely to be an important rate-limiting step that drives rapid neoplastic evolution. Methylation and inactivation of the DNA repair genes MLH1 and MGMT (O-6-methylguanine-DNA methyltransferase) have been proposed as critical steps leading to genetic instability. Stretches of DNA rich in the bases guanine and cytosine (CpG islands; where p represents a phosphodiester bond linking adjacent cytosine and guanine bases) that are normally unmethylated may become methylated in malignant human colorectal tumors. Subsets of colorectal cancers with an unusually high number of methylated CpG islands have been described as having the 'CpG-island-methylator phenotype'. It is possible that many, if not all, CRCs with the CpG-island-methylator phenotype evolve through the serrated-polyp pathway that would, therefore, explain approximately 20% of all CRCs. The current lack of guidelines for managing serrated polyps may explain the static incidence of proximal CRC, despite the falling incidence rates for left-sided CRC during the same time period.Keywords
This publication has 54 references indexed in Scilit:
- Cell turnover of serrated adenomasThe Journal of Pathology, 2005
- BRAF Mutations in Aberrant Crypt Foci and Hyperplastic PolyposisThe American Journal of Pathology, 2005
- Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancerClinical Gastroenterology and Hepatology, 2005
- The Risk of Metachronous Neoplasia in Patients With Serrated AdenomaAmerican Journal of Clinical Pathology, 2005
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- Small Invasive Colonic Cancer Occurring in a Hyperplastic PolypEndoscopy, 2004
- Different apoptotic activity and p21 WAF1/CIP1 , but not p27 Kip1 , expression in serrated adenomas as compared with traditional adenomas and hyperplastic polyps of the colorectumZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Serrated adenoma developing into advanced colon cancer in 2 yearsThe Esophagus, 2002
- DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer?Journal of Clinical Pathology, 1999
- Genetic Alterations of Mixed Hyperplastic Adenomatous Polyps in the Colon and RectumJapanese Journal of Cancer Research, 1998